Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 401–500 of 1,006

Natalizumab restores aberrant mi RNA expression profile in multiple sclerosis and reveals a critical role for miR‐20b
Ingwersen, J., Menge, T., Wingerath, B., Kaya, D., Graf, J., Prozorovski, T., Keller, A., Backes, C., Beier, M., Scheffler, M., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.152 · Cited by 82
Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing β-interferon therapy
Singh, M., Scott, T. F. M., LaFramboise, W. A., Hu, F. Z., Post, J. C., & Ehrlich, G. D. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.034 · Cited by 82
Renewing the T cell repertoire to arrest autoimmune aggression
Muraro, P. A., & Douek, D. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.12.003 · Cited by 82
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
Kozela, E., Juknat, A., Gao, F., Kaushansky, N., Coppola, G., & Vogel, Z. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0603-x · Cited by 84
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
Hooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R. B. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35734-4 · Cited by 79
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis
Yperman, J., Becker, T., Valkenborg, D., Popescu, V., Hellings, N., Wijmeersch, B. V., & Peeters, L. M. (2020) · BMC Neurology · doi:10.1186/s12883-020-01672-w · Cited by 81
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
Ostkamp, P., Salmen, A., Pignolet, B., Görlich, D., Andlauer, T. F. M., Schulte‐Mecklenbeck, A., González‐Escamilla, G., Bucciarelli, F., Gennero, I., Breuer, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018457118 · Cited by 83
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis
Bianchimano, P., Britton, G. J., Wallach, D. S., Smith, E. M., Cox, L. M., Liu, S., Iwanowski, K., Weiner, H. L., Faith, J. J., Clemente, J. C., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01364-2 · Cited by 83
The good and the bad of neuroinflammation in multiple sclerosis
Naegele, M., & Martinꝉ, R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00003-0 · Cited by 85
Self-citation
Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity
Xu, J., Wagoner, G., Douglas, J. C., & Drew, P. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008600 · Cited by 83
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis
Boccio, P. D., Pieragostino, D., di Ioia, M., Petrucci, F., Lugaresi, A., Luca, G. D., Gambi, D., ONOFRJ, M. C., Ilio, C. D., Sacchetta, P., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.023 · Cited by 84
Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
Nath, N., Khan, M., Rattan, R., Mangalam, A. K., Makkar, R. S., de Meester, C., Bertrand, L., Singh, I., Chen, Y., Viollet, B., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.106 · Cited by 81
Experimental autoimmune encephalomyelitis – achievements and prospective advances
Batoulis, H., Recks, M. S., Addicks, K., & Küerten, S. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02794.x · Cited by 80
Th17 Cells in Periodontitis and Its Regulation by A20
Huang, N., Dong, H., Luo, Y., & Shao, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742925 · Cited by 84
Cutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 Cells
Glatigny, S., Duhen, R., Oukka, M., & Bettelli, E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102515 · Cited by 80
Cutting Edge: Mast Cells Regulate Disease Severity in a Relapsing–Remitting Model of Multiple Sclerosis
Sayed, B. A., Walker, M. E., & Brown, M. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003574 · Cited by 79
Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders
Kim, M. E., & Lee, J. S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb47010008 · Cited by 83
Myelin‐phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype
van Rossum, D., Hilbert, S., Straßenburg, S., Hanisch, U., & Brück, W. (2008) · Glia · doi:10.1002/glia.20611 · Cited by 66
Immunology of multiple sclerosis
Pender, M. P., & Greer, J. M. (2007) · Current Allergy and Asthma Reports · doi:10.1007/s11882-007-0043-x · Cited by 79
Metalloproteinases Control Brain Inflammation Induced by Pertussis Toxin in Mice Overexpressing the Chemokine CCL2 in the Central Nervous System
Toft‐Hansen, H., Buist, R. J., Sun, X.-J., Schellenberg, A. E., Peeling, J., & Owens, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7242 · Cited by 80
The safety profile of cyclophosphamide in multiple sclerosis therapy
Perini, P., Calabrese, M., Rinaldi, L., & Gallo, P. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.183 · Cited by 79
Alemtuzumab long-term immunologic effect
Mercanti, S. F. D., Rolla, S., Cucci, A., Bardina, V., Cocco, E. E., Vladić, A., Soldo-Butković, S., Habek, M., Adamec, I., Horáková, D., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000194 · Cited by 79
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination
Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., Veenstra, M., Ouyang, W., Ransohoff, R. M., & Li, X. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0841-12.2012 · Cited by 78
Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
Pilli, D., Zou, A., Tea, F., Dale, R. C., & Brilot, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00652 · Cited by 81
Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
Gambuzza, M. E., Licata, N., Palella, E., Celi, D., Cuzzola, V. F., Italiano, D., Marino, S., & Bramanti, P. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.010 · Cited by 78
The role of regulatory T cells in neurodegenerative diseases
HeFeng, F. Q., & Balling, R. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1187 · Cited by 80
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
Rahimi, A., Faizi, M., Talebi, F., Noorbakhsh, F., Kahrizi, F., & Naderi, N. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.030 · Cited by 81
Antibodies as biological markers for pathophysiological processes in MS
Reindl, M., Khalil, M., & Berger, T. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.028 · Cited by 78
Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study
Hagman, S., Raunio, M., Rossi, M. E., Dastidar, P., & Elovaara, I. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.02.009 · Cited by 77
Mesenchymal stromal cells and autoimmunity
Pistoia, V., & Raffaghello, L. (2017) · International Immunology · doi:10.1093/intimm/dxx008 · Cited by 77
T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments
Engelhardt, B. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2010.009.x · Cited by 86
Myelin architecture: zippering membranes tightly together
Bakhti, M., Aggarwal, S., & Simons, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1492-0 · Cited by 80
Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients
Benzel, F. J., Erdur, H., Köhler, S., Frentsch, M., Thiel, A., Harms, L., Wandinger, K., & Rosche, B. (2011) · Journal of Helminthology · doi:10.1017/s0022149x11000460 · Cited by 77
Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Hernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis
Paula, M. L. D., Rodrigues, D. H., Teixeira, H. C., Barsante, M. M., de Souza, M. A., & Ferreira, A. P. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.05.002 · Cited by 77
Immune regulatory CNS-reactive CD8+ T cells in experimental autoimmune encephalomyelitis
York, N., Mendoza, J. P., Ortega, S. B., Benagh, A., Tyler, A. F., Firan, M., & Karandikar, N. J. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.01.003 · Cited by 77
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing–remitting multiple sclerosis patients
Ngono, A. E., Pettré, S., Salou, M., Bahbouhi, B., Soulillou, J., Brouard, S., & Laplaud, D. A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.05.009 · Cited by 79
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica
Hertwig, L., Pache, F. C., Romero‐Suárez, S., Stürner, K. H., Borisow, N., Behrens, J. R., Bellmann–Strobl, J., Seeger, B., Asselborn, N., Ruprecht, K., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515586084 · Cited by 77
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
Burman, J., Raininko, R., Blennow, K., Zetterberg, H., Axelsson, M., & Malmeström, C. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.013 · Cited by 81
MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O -GlcNAc Transferase
Liu, R., Ma, X., Chen, L., Yang, Y., Zeng, Y., Gao, J., Jiang, W., Zhang, F., Li, D., Han, B., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601727 · Cited by 77
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis
Fox, E., Edwards, K. R., Burch, G., Wynn, D. R., LaGanke, C., Crayton, H. J., Hunter, S. F., Huffman, C., Kim, E., Pestreich, L. K., et al. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.06.005 · Cited by 76
Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury
Derfuss, T. J., Linington, C., Hohlfeld, R., & Meinl, E. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0632-3 · Cited by 78
The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration
Chen, Y., Chu, J. M. T., Chang, R. C., & Wong, G. T. C. (2022) · Biomolecules · doi:10.3390/biom12020337 · Cited by 78
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications
Galoppin, M., Kari, S., Soldati, S. G., Pal, A., Rival, M., Engelhardt, B., Astier, A., & Thouvenot, É. (2022) · Brain Communications · doi:10.1093/braincomms/fcac171 · Cited by 83
Notch3 Inhibition in Myelin-Reactive T Cells Down-Regulates Protein Kinase Cθ and Attenuates Experimental Autoimmune Encephalomyelitis
Juryńczyk, M., Jurewicz, A., Raine, C. S., & Selmaj, K. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2634 · Cited by 76
LINGO-1 antagonists as therapy for multiple sclerosis:in vitroandin vivoevidence
Rudick, R. A., Mi, S., & Sandrock, A. W. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1561 · Cited by 76
Emerging topics and new perspectives on HLA-G
Fainardi, E., Castellazzi, M., Stignani, M., Morandi, F., Sana, G., Gonzalez, R., Pistoia, V., Baricordi, O. R., Sokal, E. M., & Peña, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0584-3 · Cited by 76
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis
Pieragostino, D., D’Alessandro, M., di Ioia, M., Rossi, C., Zucchelli, M., Urbani, A., Ilio, C. D., Lugaresi, A., Sacchetta, P., & Boccio, P. D. (2015) · Molecular BioSystems · doi:10.1039/c4mb00700j · Cited by 76
B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients
Schneider, R., Mohebiany, A. N., Ifergan, I., Beauseigle, D., Duquette, P., Prat, A., & Arbour, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100885 · Cited by 76
Getting specific: monoclonal antibodies in multiple sclerosis
Lutterotti, A., & Martinꝉ, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70110-8 · Cited by 77
Self-citation
Upregulation of K2P5.1 potassium channels in multiple sclerosis
Bittner, S., Bobak, N., Herrmann, A. M., Göbel, K., Meuth, P., Höhn, K., Stenner, M., Budde, T., Wiendl, H., & Meuth, S. G. (2010) · Annals of Neurology · doi:10.1002/ana.22010 · Cited by 76
The Future of Genomic Profiling of Neurological Diseases Using Blood
Sharp, F. R., Xu, H., Lit, L., Walker, W. L., Apperson, M., Gilbert, D. L., Glauser, T. A., Wong, B. L. Y., Hershey, A. D., Liu, D.-Z., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1529 · Cited by 76
Peroxisome proliferator‐activated receptor‐α agonist fenofibrate regulates IL‐12 family cytokine expression in the CNS: relevance to multiple sclerosis
Xu, J., Racke, M. K., & Drew, P. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04875.x · Cited by 76
Autoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 75
Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation
Karnell, F. G., Lin, D. Y., Motley, S., Duhen, T., Lim, N., Campbell, D., Turka, L. A., Maecker, H. T., & Harris, K. M. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12985 · Cited by 75
MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of Autoimmune Neuroinflammation
Ghorbani, S., Talebi, F., Chan, W. F., Masoumi, F., Vojgani, M., Power, C., & Noorbakhsh, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00758 · Cited by 75
Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF
Malmeström, C., Lycke, J., Haghighi, S., Andersen, O., Carlsson, L. M. S., Wadenvik, H., & Olsson, B. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.03.001 · Cited by 75
miR26a Modulates Th17/Treg Balance in the EAE Model of Multiple Sclerosis by Targeting IL6
Zhang, R., Tian, A., Wang, J., Shen, X., Qi, G., & Tang, Y. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8335-5 · Cited by 76
Environmental factors and their regulation of immunity in multiple sclerosis
Koch, M. W., Metz, L. M., Agrawal, S. M., & Yong, V. W. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.10.021 · Cited by 82
Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells
Kruglov, A., Lampropoulou, V., Fillatreau, S., & Nedospasov, S. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100663 · Cited by 75
Loss of electrostatic cell-surface repulsion mediates myelin membrane adhesion and compaction in the central nervous system
Bakhti, M., Snaidero, N., Schneider, D., Aggarwal, S., Möbius, W., Janshoff, A., Eckhardt, M., Nave, K., & Simons, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220104110 · Cited by 76
Anti-Inflammatory Effect of Wogonin on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-Polycytidylic Acid
Lee, J., & Park, W. (2015) · Molecules · doi:10.3390/molecules20046888 · Cited by 75
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., Alfieri, D. F., Flauzino, T., Lopes, J., de Carvalho Jennings Pereira, W. L., de Meleck Proença, C., Borelli, S. D., Kaimen-Maciel, D. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9846-x · Cited by 75
Experimental Optic Neuritis Induced by a Demyelinating Strain of Mouse Hepatitis Virus
Shindler, K. S., Kenyon, L. C., Dutt, M., Hingley, S. T., & Sarma, J. D. (2008) · Journal of Virology · doi:10.1128/jvi.00920-08 · Cited by 74
Immunity to self and self-maintenance: a unified theory of brain pathologies
Schwartz, M., & Ziv, Y. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.01.003 · Cited by 75
Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis
Saxena, A., Martin‐Blondel, G., Mars, L. T., & Liblau, R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.047 · Cited by 81
Production of IL ‐27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses
Sénécal, V., Deblois, G., Beauseigle, D., Schneider, R., Brandenburg, J., Newcombe, J., Moore, C. S., Prat, A., Antel, J. P., & Arbour, N. (2015) · Glia · doi:10.1002/glia.22948 · Cited by 74
The Effects of Stressful Life Events on the Course of Multiple Sclerosis: A Review
Mitsonis, C., Potagas, C. M., Zervas, I. M., & Sfagos, K. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802480192 · Cited by 73
IL-13 Production by Regulatory T Cells Protects against Experimental Autoimmune Encephalomyelitis Independently of Autoantigen
Ochoa‐Repáraz, J., Rynda, A., Ascón, M. A., Yang, X., Kochetkova, I., Riccardi, C., Callis, G. M., Trunkle, T., & Pascual, D. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.954 · Cited by 74
Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis
Reyes, J. L., Espinoza-Jiménez, A., González, M. I., Verdín, L., & Terrazas, L. I. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.11.006 · Cited by 73
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-β treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression
Krakauer, M., Sørensen, P. S., Khademi, M., Olsson, T. P., & Sellebjerg, F. T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507087136 · Cited by 73
Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions
Seabrook, T. J., Littlewood-Evans, A., Brinkmann, V., Pöllinger, B., Schnell, C., & HIESTAND, P. C. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-95 · Cited by 73
Loss of G as6 and A xl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure
Ray, A. K., DuBois, J. C., Gruber, R. C., Guzik, H. M., Gulinello, M. E., Perumal, G. S., Raine, C. S., Kozakiewicz, L., Williamson, J., & Shafit‐Zagardo, B. (2017) · Glia · doi:10.1002/glia.23214 · Cited by 74
The Gut Microbiome in Neuromyelitis Optica
Zamvil, S. S., Spencer, C. M., Baranzini, S. E., & Cree, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0594-z · Cited by 73
Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
Titus, H. E., Chen, Y., Podojil, J. R., Robinson, A. P., Balabanov, R. D., Popko, B., & Miller, S. D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.599717 · Cited by 88
Invariant NKT Cells Regulate Experimental Autoimmune Encephalomyelitis and Infiltrate the Central Nervous System in a CD1d-Independent Manner
Mars, L. T., Gautron, A.-S., Novák, J., Beaudoin, L., Diana, J., Liblau, R., & Lehuen, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2321 · Cited by 72
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
Feng, X., Reder, N. P., Yanamandala, M., Hill, A., Franek, B. S., Niewold, T. B., Reder, A. T., & Javed, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.032 · Cited by 72
Genomics in multiple sclerosis—Current state and future directions
Comabella, M., & Martinꝉ, R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.02.009 · Cited by 72
Self-citation
The Classic Basic Protein of Myelin – Conserved Structural Motifs and the Dynamic Molecular Barcode Involved in Membrane Adhesion and Protein-Protein Interactions
Harauz, G., & Libich, D. S. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309788452218 · Cited by 72
Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis
Lu, M. S., Taylor, B. V., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00477 · Cited by 74
Regulatory T Cell Vaccination without Autoantigen Protects against Experimental Autoimmune Encephalomyelitis
Ochoa‐Repáraz, J., Riccardi, C., Rynda, A., Jun, S., Callis, G. M., & Pascual, D. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1791 · Cited by 71
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis
Nakatsuji, Y., Okuno, T., Moriya, M., Sugimoto, T., Kinoshita, M., Takamatsu, H., Nojima, S., Kimura, T., Kang, S., Ito, D., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102023 · Cited by 71
Expression of TWEAK and Its Receptor Fn14 in the Multiple Sclerosis Brain: Implications for Inflammatory Tissue Injury
Serafini, B., Magliozzi, R., Rosicarelli, B., Reynolds, R., Zheng, T. S., & Aloisi, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818dab90 · Cited by 72
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
Hedegaard, C. J., Chen, N., Sellebjerg, F. T., Sørensen, P. S., Leslie, R. G. Q., Bendtzen, K., & Nielsen, C. H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02999.x · Cited by 71
Multiple Sclerosis: Overview of Disease-Modifying Agents
Finkelsztejn, A. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13213 · Cited by 71
Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis
Apel, A., Greim, B., König, N. H., & Zettl, U. K. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0217-9 · Cited by 71
Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis
Casiraghi, C., Shanina, I., Cho, S., Freeman, M. L., Blackman, M. A., & Horwitz, M. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002715 · Cited by 71
Natural triterpenes modulate immune‐inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis
Martín, R., Hernández, M., Córdova, C., & Nieto, M. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01869.x · Cited by 71
Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals
Patergnani, S., Castellazzi, M., Bonora, M., Marchi, S., Casetta, I., Pugliatti, M., Giorgi, C., Granieri, E., & Pinton, P. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316234 · Cited by 71
FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
Wang, Z., Kawabori, M., & Houkin, K. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190308133732 · Cited by 71
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis
Unoda, K., Doi, Y., Nakajima, H., Yamane, K., Hosokawa, T., Ishida, S., Kimura, F., & Hanafusa, T. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.003 · Cited by 70
Comparative Expression of Human Endogenous Retrovirus-W Genes in Multiple Sclerosis
Antony, J. M., Zhu, Y. T., Izad, M. H., Warren, K. G., Vodjgani, M., Mallet, F., & Power, C. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0274 · Cited by 72
Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice
Wang, J., Qi, Y., Niu, X., Tang, H., Meydani, S. N., & Wu, D. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.004 · Cited by 70
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
Cohen, J. A., Tenenbaum, N., Bhatt, A., Zhang, Y., & Kappos, L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419878324 · Cited by 70
Peripheral blood biomarkers in multiple sclerosis
D’Ambrosio, A., Pontecorvo, S., Colasanti, T., Zamboni, S., Francia, A., & Margutti, P. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.014 · Cited by 70
Novel Immunomodulatory Properties of Berbamine through Selective Down-Regulation of STAT4 and Action of IFN-γ in Experimental Autoimmune Encephalomyelitis
Ren, Y., Lü, L., Guo, T. B., Qiu, J., Yang, Y., Liu, A., & Zhang, J. Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1491 · Cited by 70
Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate
Jung, S., Siglienti, I., Grauer, O. M., Magnus, T., Scarlato, G., & Toyka, K. V. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.014 · Cited by 70
Endogenous self-peptides guard immune privilege of the central nervous system
Kim, M. W., Gao, W., Lichti, C. F., Gu, X., Dykstra, T., Cao, J., Smirnov, I., Boskovic, P., Kleverov, D., Salvador, A. F., et al. (2024) · Nature · doi:10.1038/s41586-024-08279-y · Cited by 75
EBV in MS: guilty by association?
Lünemann, J. D., & Münz, C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.007 · Cited by 70
STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination
Lu, H. C., Kim, S.-J., Steelman, A. J., Tracy, K., Zhou, B., Michaud, D., Hillhouse, A., Konganti, K., & Li, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913997117 · Cited by 72

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks